Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.390
0.00 (0.00%)
Jul 17, 2026, 5:35 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.37 billion as of July 17, 2026. Its market cap has decreased by -2.87% in one year.
Market Cap
1.37B
Enterprise Value
1.67B
Revenue
674.06M
Ranking
n/a
PE Ratio
16.68
Stock Price
€4.39
ChartMarket Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.37B, an increase of 735.26%. That is a compound annual growth rate of 6.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.37B | -14.92% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.44B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.32B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 935.48M |
| Oryzon Genomics | 237.84M |
| Prim, S.A. | 226.28M |
| Laboratorio Reig Jofre | 213.30M |